Jpmorgan Chase & Co »

Tarsus Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Tarsus Pharmaceuticals (TARS) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Tarsus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Tarsus Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tarsus Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $518k 26k 20.25
2023-09-30 $393k 22k 17.77
2023-06-30 $347k 19k 18.07
2023-03-31 $188k 15k 12.56
2022-12-31 $173k 11k 15.22
2022-06-30 $142k 9.7k 14.65
2022-03-31 $67k 4.0k 16.94
2021-12-31 $3.9M 175k 22.50
2021-03-31 $351k 11k 32.15
2020-12-31 $697k 17k 41.51